Premier Alternatives

South Rampart Pharma

San Rafael, CA · Founded 2016 · Privately Held (backing)

Developer of a clinical-stage biotech company designed to address the need for a safe and effective approach to relieving pain. South Rampart Pharma is based in San Rafael, CA and was founded in 2016. Its last reported valuation was $73 million in Jan 2025. It has raised $9.1 million.

Last reported valuation
$73.0M
Oct 2026
Priced at
—
Total raised
$9.1M
Last round
—

South Rampart Pharma key facts

as of Oct 2026
  • Developer of a clinical-stage biotech company designed to address the need for a safe and effective approach to relieving pain.
  • South Rampart Pharma is valued at approximately $73.0M as of Oct 2026 (last reported valuation).
  • It has raised $9.1M; the latest was Later Stage VC ($3.2M) in Jan 2025.
  • Notable investors include Gulf South Angels, Louisiana Economic Development, National Institutes of Neurological Disorders and Stroke, Ochsner Health, Ochsner Ventures — 6 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$73.0M

South Rampart Pharma's last reported valuation, Jan 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of South Rampart Pharma with a free account
  • ·Watch South Rampart Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

South Rampart Pharma funding rounds

No rounds on record

No funding rounds for South Rampart Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

South Rampart Pharma valuation

South Rampart Pharma's last reported valuation was $73 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.

South Rampart Pharma investors

6 investors are on record for South Rampart Pharma, including Gulf South Angels, Louisiana Economic Development, National Institutes of Neurological Disorders and Stroke and Ochsner Health.

About South Rampart Pharma

Developer of a clinical-stage biotech company designed to address the need for a safe and effective approach to relieving pain. The company develops synthesized and characterized new non-opioid and non-liver toxic molecules that activate pain signaling pathways in the midbrain's periaqueductal grey (PAG) region, enabling patients to overcome risks associated with current pain medicines, including lack of abuse as a non-opioid and no liver toxicity.

Sector
Healthcare
HQ
San Rafael, CA, United States
Founded
2016
Employees
4
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.